These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35702767)

  • 1. Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
    Kinscherf NA; Pehar M
    Curr Drug Targets; 2022; 23(12):1191-1209. PubMed ID: 35702767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.
    Koerich S; Parreira GM; de Almeida DL; Vieira RP; de Oliveira ACP
    Curr Neuropharmacol; 2023; 21(2):219-234. PubMed ID: 36154605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE and its ligands: from pathogenesis to therapeutics.
    Jangde N; Ray R; Rai V
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors.
    Singh H; Agrawal DK
    Drug Dev Res; 2022 Sep; 83(6):1257-1269. PubMed ID: 35781678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.
    Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Receptor for Advanced Glycation End Products (RAGE) and DIAPH1: Implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system.
    MacLean M; Derk J; Ruiz HH; Juranek JK; Ramasamy R; Schmidt AM
    Neurochem Int; 2019 Jun; 126():154-164. PubMed ID: 30902646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of RAGE Axis Signaling: A Pharmacological Challenge.
    Rojas A; Morales M; Gonzalez I; Araya P
    Curr Drug Targets; 2019; 20(3):340-346. PubMed ID: 30124149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RAGE signaling in osteoporosis.
    Zhou J; Liu S; Bi S; Kong W; Qian R; Xie X; Zeng M; Jiang X; Liao Z; Shuai M; Liu W; Cheng L; Wu M
    Biomed Pharmacother; 2023 Sep; 165():115044. PubMed ID: 37354815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
    Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
    Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
    Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
    J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
    Shekhtman A; Ramasamy R; Schmidt AM
    Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease.
    Gasparotto J; Somensi N; Girardi CS; Bittencourt RR; de Oliveira LM; Hoefel LP; Scheibel IM; Peixoto DO; Moreira JCF; Outeiro TF; Gelain DP
    J Neurochem; 2024 Aug; 168(8):1608-1624. PubMed ID: 37381043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75
    Kim MJ; Vargas MR; Harlan BA; Killoy KM; Ball LE; Comte-Walters S; Gooz M; Yamamoto Y; Beckman JS; Barbeito L; Pehar M
    Antioxid Redox Signal; 2018 Jun; 28(18):1587-1602. PubMed ID: 28537420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
    Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
    Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
    Teissier T; Boulanger É
    Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease.
    Batkulwar K; Godbole R; Banarjee R; Kassaar O; Williams RJ; Kulkarni MJ
    ACS Chem Neurosci; 2018 May; 9(5):988-1000. PubMed ID: 29384651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
    Bongarzone S; Savickas V; Luzi F; Gee AD
    J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAGE Isoforms, its Ligands and their Role in Pathophysiology of Alzheimer's Disease.
    Chellappa RC; Palanisamy R; Swaminathan K
    Curr Alzheimer Res; 2020; 17(14):1262-1279. PubMed ID: 33602095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE pathways play an important role in regulation of organ fibrosis.
    Liu J; Jin Z; Wang X; Jakoš T; Zhu J; Yuan Y
    Life Sci; 2023 Jun; 323():121713. PubMed ID: 37088412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.